High expression of the Met receptor in prostate cancer metastasis to bone

Urology

Volumn 60, Issue 6, 2002, Pages 1113-1117

  Knudsen, Beatrice S ^a,b,c,d,e   Gmyrek, Glenn A ^a,b,c,d   Inra, Jennifer ^a,b,c,d   Scherr, Douglas S ^a,b,c,d   Vaughan, E Darracott ^a,b,c,d   Nanus, David M ^a,b,c,d   Kattan, Michael W ^a,b,c,d   Gerald, William L ^a,b,c,d   Vande Woude, George F ^a,b,c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d VAN ANDEL RESEARCH INSTITUTE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR;

ARTICLE; BONE METASTASIS; CANCER CELL; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SOFT TISSUE METASTASIS; WESTERN BLOTTING;

BONE NEOPLASMS; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET;

EID: 0036899998     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01954-4     Document Type: Article

References (15)

1. Grano M., Galimi F., Zambonin G., et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA. 93:1996;7644-7648.
2. Gmyrek G.A., Walburg M., Webb C.P., et al. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol. 159:2001;579-590.
3. Humphrey P.A., Zhu X., Zarnegar R., et al. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol. 147:1995;386-396.
4. Pisters L.L., Troncoso P., Zhau H.E., et al. c-Met proto-oncogene expression in benign and malignant human prostate tissues. J Urol. 154:1995;293-298.
5. Watanabe M., Fukutome K., Kato H., et al. Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers. Cancer Lett. 141:1999;173-178.
6. Jeffers M., Rong S., Woude G.F. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med. 74:1996;505-513.
7. Schmidt L., Duh F.M., Chen F., et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 16:1997;68-73.
8. Rong S., Segal S., Anver M., et al. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA. 91:1994;4731-4735.
9. Rong S., Jeffers M., Resau J.H., et al. Met expression and sarcoma tumorigenicity. Cancer Res. 53:1993;5355-5360.
10. Maulik G., Shrikhande A., Kijima T., et al. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 13:2002;41-59.
11. De Marzo A.M., Knudsen B., Chan-Tack K., et al. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology. 53:1999;707-713.
12. Isaacs J.T. The biology of hormone refractory prostate cancer why does it develop? Urol Clin North Am. 26:1999;263-273.
13. De Marzo A.M., Nelson W.G., Meeker A.K., et al. Stem cell features of benign and malignant prostate epithelial cells. J Urol. 160:1998;2381-2392.
14. Liu Y., Centracchio J.N., Lin L., et al. Constitutive expression of HGF modulates renal epithelial cell phenotype and induces c-met and fibronectin expression. Exp Cell Res. 242:1998;174-185.
15. Koeneman K.S., Yeung F., Chung L.W. Osteomimetic properties of prostate cancer cells a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment . Prostate. 39:1999;246-261.